Moreover, the FXR ligand induces a decrease on leptin-mediated up-regulation of its own gene (Ob) expression, highlighting how this nuclear receptor is able to negatively interfere in the short autocrine loop maintained by leptin on Ob gene in breast cancer cells. The gene discussed is LEP; the disease is breast cancer.